Skip to main content
. 2018 Oct 18;13:3399–3410. doi: 10.2147/COPD.S174156

Figure 1.

Figure 1

CHF6001 plasma pharmacokinetic–time profile following single doses (PK population).

Notes: Data are mean. PK population is defined as all subjects in the safety population who had at least one valid PK measurement and who had no major PK-related protocol deviations.

Abbreviations: PK, pharmacokinetics; MDDPI, study medication administered via multi-dose dry-powder inhaler; SDDPI, study medication administered via single-dose dry-powder inhaler.